☆ 4.7 Article

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

LEUKEMIA (2020)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 34, Issue 10, Pages 2798-2804

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41375-020-0844-7

Keywords

-

Categories

Oncology Hematology

Funding

  1. Howard Hughes Medical Institute (HHMI)
  2. Leukemia & Lymphoma Society [LLS SCOR 7005-11]
  3. National Cancer Institute [1R01CA214428, 1U01CA217862, 5U01CA214116, 1U54CA224019, 1F30CA239335-02, 1R01CA183947, 3P30CA069533]
  4. ARCS Scholar Foundation
  5. Paul & Daisy Soros Fellowship
  6. American Cancer Society [MRSG-17-040-01-LIB]
  7. V Foundation for Cancer Research
  8. Mark Foundation
  9. Gabrielle's Angel Foundation for Cancer Research

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.